The Clinical Obsearvation Of RN22 Deep Needling Combined With Balloon Dilation Therapy In The Treatment Of Dysphagia After Stroke

1 ObjectiveThis study is to observe the clinical efficacy of the treatment RN22 deep needling with balloon dilation after stroke dysphagia,providing an objective basis for clinical application.2 MethodThe experimental design method this study used a randomized method.66patients with dysphagia after stroke were selected according to the inclusion criteria of the study,randomly divided into observation group(n = 33)and control group(n = 33).Before treatment,two groups of patients were evaluated by Kubota water test,Fujishima Ichiro swallowing Response Evaluation Criteria.Under same basic therapy,observation group was treated with RN22 deep needling with balloon dilation three times a week,while control group treated with only balloon dilation three times a week.After three weeks of treatment,two groups of patients were evaluated by Kubota water test,Fujishima Ichiro swallowing Response Evaluation Criteria again.Adverse events would be recorded during the test.The data of the two groups was analyzed by SPSS19.0 software,comparing the improvement of swallowing function between the two groups before and after treatment.Count data were analyzed by χ2 test,measurement data was used in t test,and ranked data was used in Wilcoxon rank sum test.P<0.05 was considered statistically significant..3 Result3.1 baseline dataThe study included 66 patients with dysphagia after stroke in Wangjing Hospital of China Academy of Chinese Medical Sciences during May 2016 to January 2017,divided into observation group(n = 33)and control group(n = 33).Data analysis using the compliance scheme,two example drop because of not adhering study so that observation group were 32 left as the same as control group.There were 47 males and 17 females.The mean age of the patients was 63.04 years old,and the mean course of disease was about 10 weeks.The average grade of Kubota water test was rated as grade 4.06Analyzing and evaluating the gender,age,course of disease and severity of the two groups before testing,results showed no significant difference(P>0.05)between the two groups,indicating the two groups were comparable in baseline data.3.2 Comparison of clinical efficacyAfetr three weeks of treatment,observing the change of Kubota water test,Fujishima Ichiro swallowing Response Evaluation Criteria,there were statiscally significant differences in various data between pretreatmen and posttreatment(P<0.01).The data of two scale showed that the differences between the two groups about posttreatmeng were significantly different statistically(P<0.05).As efficiency showed,obvertion group were cured 4 cases,effective in 22 cases,invalid in 6 cases,total effective rate was 81.25%;while control group,3 patients were cured,effective in 12 cases,invalid in 10 cases,the total effective rate was 46.86%.There were significant differences between the two groups,Z =-2.503,P=0.012<0.05.4 SafetyNo adverse reactions occurred during the trial,which proved safe and reliable in this study.5 Conclusion① Both RN22 deep needling with ballon dilatation therapy and ballon dilatation therapy only effective for stroke dysphagia.② N22 deep needling with ballon dilatation therapy is better than ballon dilatation therapy only in treatment of dysphagia after stroke.